眼瞼成形術市場規模、佔有率和成長分析(按類型、技術、性別、服務提供者和地區分類)—2026-2033年產業預測
市場調查報告書
商品編碼
1896944

眼瞼成形術市場規模、佔有率和成長分析(按類型、技術、性別、服務提供者和地區分類)—2026-2033年產業預測

Blepharoplasty Market Size, Share, and Growth Analysis, By Type, By Technology, By Gender, By Service Provider, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,眼瞼成形術市場規模將達到 39.9 億美元,到 2025 年將成長至 43 億美元,到 2033 年將成長至 77.2 億美元,在預測期(2026-2033 年)內,複合年成長率為 7.6%。

眼瞼整形市場正經歷顯著成長,這主要得益於人口老化,人們尋求有效解決常見的與老齡化相關的眼瞼下垂和皺紋等問題。隨著人們對微創手術的需求日益成長,眼瞼整形術已成為那些希望改善眼部美觀和功能的人士的首選。此手術能夠有效矯正眼瞼下垂,去除多餘的脂肪組織,從而減輕眼部浮腫並改善視力。人們對眼瞼整形術益處的認知不斷提高,加上眼瞼畸形的盛行率不斷上升,共同推動了市場需求。因此,隨著越來越多的人重視自身形象和健康並尋求針對性治療,預計該行業將繼續擴張。

眼瞼成形術市場成長要素

眼部疾病,尤其是老年人中眼部疾病發生率的上升趨勢,預計將推動眼瞼整形術市場的擴張。眼瞼下垂、視力障礙和眼周皺紋等眼科疾病的增多,導致人們對眼瞼整形術的興趣日益濃厚。隨著越來越多的人尋求解決這些問題的方法,預計對這類手術的需求將會增加。此外,對美觀效果的追求也促進了市場的發展,因為越來越多的患者希望在解決功能性問題的同時,改善臉部外觀。

限制眼瞼成形術市場的因素

眼瞼整形市場面臨許多可能阻礙其發展的重大挑戰。其中主要問題之一是手術費用高昂,這可能會讓潛在患者望而卻步。此外,眼瞼整形術的併發症,如乾眼症、肌肉損傷和明顯疤痕等,也會令患者感到焦慮。這些因素可能導致患者和醫生都持謹慎態度,從而限制手術需求並影響市場整體擴張。因此,這些阻礙因素可能會顯著減緩眼瞼整形領域的發展。

眼瞼成形術市場趨勢

眼瞼整形市場正經歷著顯著的發展趨勢,這主要得益於消費者對提升外觀的日益重視以及對整形手術選擇的認知不斷提高。這種轉變在千禧世代中尤其明顯,他們非常注重外表和自我護理,同時可支配收入的增加也使他們能夠選擇進行一些非手術項目。此外,醫療費用支出的成長也促進了人們對整形手術的接受度和可近性。隨著越來越多的人尋求解決眼周老化和疲勞徵兆的方法,眼瞼整形的需求持續成長,並在整個整形外科領域佔據了重要地位。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 監管環境
  • 客戶和購買標準分析

全球眼瞼成形術市場規模(按類型及複合年成長率分類)(2026-2033 年)

  • 上瞼成形術
  • 下瞼成形術
  • 複雜眼瞼手術
  • 其他

全球眼瞼成形術市場規模(依技術及複合年成長率分類)(2026-2033 年)

  • 等離子弧技術
  • 血漿纖維母細胞療法

全球眼瞼整形市場規模:性別與複合年成長率(2026-2033)

  • 女士
  • 男性

全球眼瞼成形術市場規模(按服務提供者分類)及複合年成長率(2026-2033 年)

  • 醫院
  • 診所
  • 門診

全球眼瞼成形術市場規模(按地區分類)及複合年成長率(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2021-2023年營收年比比較

主要企業簡介

  • AbbVie Inc.(USA)
  • Cutera Inc.(USA)
  • Cynosure Inc.(USA)
  • Erchonia Corporation(USA)
  • Hologic Inc.(USA)
  • Lumenis Ltd.(Israel)
  • Merz Pharma GmbH & Co. KGaA(Germany)
  • Sciton Inc.(USA)
  • Alma Lasers Ltd.(Israel)
  • Bausch Health Companies Inc.(Canada)
  • El.En. SpA(Italy)
  • Fotona doo(Slovenia)
  • InMode Ltd.(Israel)
  • Lutronic Corporation(South Korea)
  • Solta Medical Inc.(USA)
  • Valeant Pharmaceuticals International Inc.(Canada)
  • Sisram Medical Ltd.(Hong Kong)
  • Medtronic plc(Ireland)
  • LightScalpel Inc.(USA)
  • Grand Aespio Inc.(South Korea)

結論與建議

簡介目錄
Product Code: SQMIG35E2015

Blepharoplasty Market size was valued at USD 3.99 Billion in 2024 and is poised to grow from USD 4.3 Billion in 2025 to USD 7.72 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The blepharoplasty market is experiencing significant growth, fueled by the rising aging population that seeks effective solutions for common age-related issues such as sagging and wrinkling eyelids. As the desire for minimally invasive surgical options continues to rise, blepharoplasty has emerged as a preferred choice for individuals looking to enhance both the aesthetics and functionality of their eyes. This surgical procedure effectively addresses drooping eyelids and removes excess fatty deposits, alleviating puffiness and improving vision. The increasing awareness of blepharoplasty's benefits, coupled with the growing prevalence of eyelid deformities, is driving demand. Consequently, the sector is poised for continued expansion as more individuals prioritize their appearance and well-being through targeted treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blepharoplasty market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blepharoplasty Market Segments Analysis

Global Blepharoplasty Market is segmented by type, technology, gender, service provider and region. Based on type, the market is segmented into upper eyelid blepharoplasty, lower eyelid blepharoplasty, combination eyelid surgery and others. Based on technology, the market is segmented into ARC technology and fibro blasting plasma technology. Based on gender, the market is segmented into female and male. Based on service provider, the market is segmented into hospitals, clinics and ambulatory. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Blepharoplasty Market

The growing incidence of eye-related conditions, especially among the aging population, is expected to fuel the expansion of the blepharoplasty market. A rise in eye disorders such as ptosis, impaired vision, and the appearance of wrinkles around the eyes is leading to a heightened interest in blepharoplasty procedures. As more individuals seek solutions for these concerns, the demand for these surgical interventions is likely to increase. Furthermore, the pursuit of improved aesthetic outcomes is also contributing to the market's development, as patients look for ways to enhance their facial appearance while addressing functional issues associated with their eyes.

Restraints in the Blepharoplasty Market

The blepharoplasty market faces several significant challenges that could hinder its growth. One of the primary concerns is the high cost associated with these procedures, which may deter potential patients from seeking treatment. Additionally, complications related to blepharoplasty, such as the development of dry eyes, potential muscle damage, and noticeable scarring, contribute to patient apprehension. These factors create a cautious environment for both patients and practitioners, potentially limiting the demand for such procedures and impacting overall market expansion. As a result, these restraints could slow progress within the blepharoplasty sector significantly.

Market Trends of the Blepharoplasty Market

The blepharoplasty market is experiencing a notable trend driven by a growing consumer inclination towards aesthetic enhancement and heightened awareness of cosmetic surgical options. This shift is particularly evident among millennials, who prioritize appearance and self-care, coupled with an increase in disposable income that allows for elective procedures. Additionally, rising healthcare expenditures contribute to the acceptance and accessibility of surgical interventions. As more individuals seek solutions to address signs of aging and fatigue around the eyes, the demand for blepharoplasty continues to rise, positioning it as a key player in the broader cosmetic surgery landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Global Blepharoplasty Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Upper Eyelid Blepharoplasty
  • Lower Eyelid Blepharoplasty
  • Combination Eyelid Surgery
  • Others

Global Blepharoplasty Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • ARC Technology
  • Fibro Blasting Plasma Technology

Global Blepharoplasty Market Size by Gender & CAGR (2026-2033)

  • Market Overview
  • Female
  • Male

Global Blepharoplasty Market Size by Service Provider & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Clinics
  • Ambulatory

Global Blepharoplasty Market Size & CAGR (2026-2033)

  • North America (Type, Technology, Gender, Service Provider)
    • US
    • Canada
  • Europe (Type, Technology, Gender, Service Provider)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Gender, Service Provider)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Gender, Service Provider)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Gender, Service Provider)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • AbbVie Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cutera Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cynosure Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Erchonia Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lumenis Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Pharma GmbH & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sciton Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alma Lasers Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch Health Companies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • El.En. S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fotona d.o.o. (Slovenia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InMode Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lutronic Corporation (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solta Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valeant Pharmaceuticals International Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sisram Medical Ltd. (Hong Kong)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LightScalpel Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grand Aespio Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations